CLPT
Clearpoint Neuro Inc
NASDAQ: CLPT · HEALTHCARE · MEDICAL DEVICES
$11.18
+8.12% today
Updated 2026-04-30
Market cap
$353.24M
P/E ratio
—
P/S ratio
9.55x
EPS (TTM)
$-0.90
Dividend yield
—
52W range
$8 – $30
Volume
0.8M
Clearpoint Neuro Inc (CLPT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-7.71M | $-6.24M | $-7.43M | $-7.78M | $-7.25M | $-8.64M | $-5.82M | $-5.99M | $-4.63M | $-2.85M | $-7.81M | $-12.70M | $-16.17M | $-13.72M | $-8.95M | $-23.93M |
| Capital expenditures | $61704.00 | $26101.00 | $127453.00 | $174469.00 | $48129.00 | $76883.00 | $101002.00 | $26752.00 | $63490.00 | $160190.00 | $482000.00 | $168000.00 | $253000.00 | $717000.00 | $275000.00 | $522000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $245462.00 | $989902.00 | $2.03M | $1.46M | $880765.00 | $1.68M | $959585.00 | $1.25M | $1.23M | $799110.00 | $1.09M | $2.08M | $4.13M | $6.08M | $6.91M | $8.18M |
| Free cash flow | $-7.77M | $-6.27M | $-7.56M | $-7.95M | $-7.30M | $-8.71M | $-5.92M | $-6.02M | $-4.69M | $-3.01M | $-8.29M | $-12.87M | $-16.42M | $-14.44M | $-9.22M | $-24.45M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | $432000.00 | $204000.00 | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | $14.40M | $34.01M | $-26.49M | — | — | — |